Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
With just five days left until the US president is set to impose the harshest measures yet in his global trade war, analysts have been racing to figure out which nations, firms and drugs could be affected.
